SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED

Shanghai HeartCare Medical Technology Corporation Limited

Equities

6609

CNE100004MN5

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 04:08:06 2024-04-30 am EDT			5-day change	1st Jan Change
17.9 ^HKD	-3.87%		+8.22%	-39.83%

Mar. 28	Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Shanghai HeartCare Offloads Stake in Medical Device Developer Shenji Medical	MT

Shanghai Heartcare Medical Technology Corporation Limited Appoints Xue Zongyu as the Chairperson of the Supervisory Committee

November 17, 2023 at 07:29 am EST

Shanghai HeartCare Medical Technology Corporation Limited announced that Xue Zongyu has been elected as the chairperson of the Supervisory Committee with a term of office commencing from November 17, 2023 and expiring at the conclusion of the second session of the Supervisory Committee with immediate effect.

Latest news about Shanghai HeartCare Medical Technology Corporation Limited

Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Shanghai HeartCare Offloads Stake in Medical Device Developer Shenji Medical	Dec. 11	MT
Shanghai Heartcare Medical Technology Corporation Limited Appoints Xue Zongyu as the Chairperson of the Supervisory Committee	Nov. 17	CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Board Changes	Nov. 08	CI
Shanghai HeartCare Medical Technology Corporation Limited(SEHK:6609) dropped from S&P Global BMI Index	23-09-18	CI
HeartCare Medical Technology's Loss Narrows in H1	23-09-01	MT
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Shanghai HeartCare Medical Technology Corporation Limited Announces Nomination Committee Changes	23-03-20	CI
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-20	CI
Shanghai Heartcare Medical Technology Corporation Limited Appoints Chen Shaoxiong as A Non-Executive Director	22-11-09	CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Chen Gang as Non-Executive Director	22-08-31	CI
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31	CI
536,714 Unlisted Foreign Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.	22-08-18	CI
6,731,890 Domestic Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.	22-08-18	CI
24,963,954 H Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.	22-08-18	CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Ouyang Xiangyu as Non-Executive Director	22-07-15	CI
Shanghai Heartcare Medical Technology Corporation Limited Appoints Wei Jiawei as an Executive Director	22-06-10	CI
Shanghai HeartCare Medical Technology Corporation Limited Voluntary Receives Approval from the National Medical Products Administration for registration application for LAA Occluder	22-04-28	CI
Shanghai Heartcare Medical Technology Corporation Limited Receives the Approvals from the National Medical Products Administration of the PRC for the Registration Applications for the Aspiration Catheter and Support Catheter	22-04-26	CI
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-28	CI
Shanghai HeartCare Medical Technology Corporation Limited Announces Change of Principal Place of Business in Hong Kong	22-03-24	CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Executive Changes	22-03-24	CI
Shanghai HeartCare Medical Technology Corporation Limited(SEHK:6609) added to S&P Global BMI Index	22-03-21	CI
Chinese Regulators OK HeartCare Medical's Registration Application for Neuro-Interventional Product	22-03-18	MT
Shanghai Heartcare Medical Technology Corporation Limited Announces Embolic Coil Received NMPA Approval	22-03-17	CI

Chart Shanghai HeartCare Medical Technology Corporation Limited

Duration

Period

Chart Shanghai HeartCare Medical Technology Corporation Limited

More charts

Company Profile

Shanghai HeartCare Medical Technology Corp Ltd is a China-based company engaged in the research and development of innovative neuro-interventional medical device. The Company's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The Company's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The Company's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The Company distributes its products within the domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Shanghai HeartCare Medical Technology Corporation Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.22 CNY

Average target price

27.12 CNY

Spread / Average Target

+57.44%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED	-39.83%	90.74M
ABBOTT LABORATORIES	-2.54%	186B
MEDTRONIC PLC	-1.85%	107B
BECTON, DICKINSON AND COMPANY	-4.26%	67.44B
DEXCOM, INC.	+1.39%	50.03B
CENCORA, INC.	+16.82%	47.81B
HOYA CORPORATION	+4.79%	41.03B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.49%	26.85B
WEST PHARMACEUTICAL SERVICES, INC.	+0.65%	25.82B
TERUMO CORPORATION	+16.55%	24.74B

Other Medical Equipment, Supplies & Distribution